Zero-order release and bioavailability enhancement of poorly water soluble Vinpocetine from self-nanoemulsifying osmotic pump tablet

References

• Abd-Elbary A, Tadros MI, Alaa-Eldin AA. 2011. Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets. AAPS PharmSciTech. 12:485–495.
   PubMed Web of Science ®Google Scholar
• Aburahma MH, El-Laithy HM, Hamza YE-S. 2010. Preparation and in vitro/in vivo characterization of porous sublingual tablets containing ternary kneaded solid system of vinpocetine with β-cyclodextrin and hydroxy acid. Sci Pharm. 78:363–379.
   PubMedGoogle Scholar
• Adibkia K, Ghanbarzadeh S, Shokri MH, Arami Z, Arash Z, Shokri J. 2014. Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former. Pharm Dev Technol. 19:507–512.
   PubMed Web of Science ®Google Scholar
• Am Ende MT, Miller LA. 2007. Mechanistic investigation of drug release from asymmetric membrane tablets: effect of media gradients (osmotic pressure and concentration), and potential coating failures on in vitro release. Pharm Res. 24:288–297.
   PubMed Web of Science ®Google Scholar
• Barzegar-Jalali M, Adibkia K, Valizadeh H, Reza Siahi Shadbad M, Nokhodchi A, Omidi Y, Mohammadi G, Hallaj Nezhadi S, Hasan M. 2008. Kinetic analysis of drug release from nanoparticles. JPPS. 11:167–177.
   Google Scholar
• Bi Y, Mao S, Gan L, Li Y, Wang C, Xu N, Zheng Y, Cheng Q, Hou S. 2007. A controlled porosity osmotic pump system with biphasic release of theophylline. Chem Pharm Bull. 55:1574–1580.
   PubMed Web of Science ®Google Scholar
• Charman W, Stella V. 1991. Transport of lipophilic molecules by the intestinal lymphatic system. Adv Drug Deliv Rev. 7:1–14.
   Web of Science ®Google Scholar
• Chen Y, Li G, Huang JG, Wang RH, Liu H, Tang R. 2009. Comparison of self-microemulsifying drug delivery system versus solid dispersion technology used in the improvement of dissolution rate and bioavailability of vinpocetine. Acta Pharm Sin. 44:658–666.
   Google Scholar
• Chen Y, Li G, Wu X, Chen Z, Hang J, Qin B, Chen S, Wang R. 2008. Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. Biol Pharm Bull. 31:118–125.
   PubMed Web of Science ®Google Scholar
• Chudasama AS, Patel VV, Nivsarkar M, Vasu KK, Shishoo CJ. 2014. In vivo evaluation of self emulsifying drug delivery system for oral delivery of nevirapine. Indian J Pharm Sci. 76:218–224.
   PubMed Web of Science ®Google Scholar
• Constantinides PP. 1995. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 12:1561–1572.
   PubMed Web of Science ®Google Scholar
• Cui S, Zhao C, Tang X, Chen D, He Z. 2005. Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography–mass spectrometry. Biomed Chromatogr. 19:375–378.
   PubMed Web of Science ®Google Scholar
• Derakhshandeh K, Berenji MG. 2014. Development and optimization of buspirone oral osmotic pump tablet. Res Pharm Sci. 9:233–241.
   PubMedGoogle Scholar
• Ding J, Li J, Mao S. 2015. Development and evaluation of vinpocetine inclusion complex for brain targeting. Asian J Pharm Sci. 10:114–120.
   Web of Science ®Google Scholar
• El-Dahmy RM, Elsayed I, Elshafeey AH, El Gawad NAA, El-Gazayerly ON. 2014. Optimization of long circulating mixed polymeric micelles containing vinpocetine using simple lattice mixture design, in vitro and in vivo characterization. Int J Pharm. 477:39–46.
   PubMed Web of Science ®Google Scholar
• El-Laithy HM, Shoukry O, Mahran LG. 2011. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies. Eur J Pharm Biopharm. 77:43–55.
   PubMed Web of Science ®Google Scholar
• El-Mahrouk GM, El-Gazayerly ON, Aboelwafa AA, Taha MS. 2014. Chitosan lactate wafer as a platform for the buccal delivery of tizanidine HCl: in vitro and in vivo performance. Int J Pharm. 467:100–112.
   PubMed Web of Science ®Google Scholar
• El-Zahaby SA, AbouGhaly MHH, Abdelbary GA, El-Gazayerly ON. 2016. Development of a novel solid self-nano-emulsifying osmotically controlled system of a centrally acting drug: preparation and in-vitro evaluation. Inventi Impact NDDS. 2016:35–49.
   Google Scholar
• European Commission. 2010. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. Off J Eur Union. L27633-79.
   Google Scholar
• Hasa D, Voinovich D, Perissutti B, Grassi M, Bonifacio A, Sergo V, Cepek C, Chierotti MR, Gobetto R, Dall’Acqua S, et al. 2011. Enhanced oral bioavailability of vinpocetine through mechanochemical salt formation: physico-chemical characterization and in vivo studies. Pharm Res. 28:1870–1883.
   PubMed Web of Science ®Google Scholar
• Haus D, Mehta S, Radebaugh G. 1994. Targeting lymphatic transport and modified systemic distribution of CI-976, a lipophilic lipid-regulator drug, via a formulation approach. Int J Pharm. 108:85–93.
   Google Scholar
• Herbig S, Cardinal J, Korsmeyer R, Smith K. 1995. Asymmetric-membrane tablet coatings for osmotic drug delivery. J Control Release. 35:127–136.
   Web of Science ®Google Scholar
• Huang Y-B, Tsai Y-H, Yang W-C, Chang J-S, Wu P-C, Takayama K. 2004. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation. Eur J Pharm Biopharm. 58:607–614.
   PubMed Web of Science ®Google Scholar
• Jeon K-I, Xu X, Aizawa T, Lim JH, Jono H, Kwon D-S, Abe J-i, Berk BC, Li J-D, Yan C. 2010. Vinpocetine inhibits NF-κB-dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proc Natl Acad Sci. 107:9795–9800.
   PubMed Web of Science ®Google Scholar
• Jha MK, Faruki M, Rahman M, Uddin Talukder M. 2012. Development and in-vitro evaluation of Vinpocetine loaded bi-layer tablet using different polymers. J Appl Pharm Sci. 2:149–157.
   Google Scholar
• Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, Lee HB, Cho SH. 2004. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 274:65–73.
   PubMed Web of Science ®Google Scholar
• Ketjinda W, Sinchaipanid N, Limsuwan P, Leuenberger H, Mitrevej A. 2011. Development of push-pull osmotic tablets using chitosan-poly(acrylic acid) interpolymer complex as an osmopolymer. AAPS PharmSciTech. 12:132–140.
   PubMed Web of Science ®Google Scholar
• Kharshoum RM, Sanad RA, Ali AMA. 2013. Comparative pharmacokinetic study of two lyophilized orally disintegrating tablets formulations of vinpocetine in human volunteers. Int J Drug Deliv. 5:167–176.
   Google Scholar
• Kommuru T, Gurley B, Khan M, Reddy I. 2001. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q 10: formulation development and bioavailability assessment. Int J Pharm. 212:233–246.
   PubMed Web of Science ®Google Scholar
• Li C-X, Wang H-B, Oppong D, Wang J-X, Chen J-F, Le Y. 2014. Excipient-assisted vinpocetine nanoparticles: experiments and molecular dynamic simulations. Mol Pharm. 11:4023–4035.
   PubMed Web of Science ®Google Scholar
• Lin C, Chen F, Ye T, Zhang L, Zhang W, Liu D, Xiong W, Yang X, Pan W. 2014. A novel oral delivery system consisting in “drug-in cyclodextrin-in nanostructured lipid carriers” for poorly water-soluble drug: vinpocetine. Int J Pharm. 465:90–96.
   PubMed Web of Science ®Google Scholar
• Lindmark T, Nikkilä T, Artursson P. 1995. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther. 275:958–964.
   PubMed Web of Science ®Google Scholar
• Luo Y, Chen D, Ren L, Zhao X, Qin J. 2006. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release. 114:53–59.
   PubMed Web of Science ®Google Scholar
• Ma Y-H, Ge S-W, Wang W, Zheng Q, Zuo Y-W, Zhong C-J, Sun B-W. 2016. Novel perchlorate and phosphate salts of vinpocetine: characterization, relative solid-state stability evaluation and Hirshfeld surface analysis. J Mol Struct. 1105:1–10.
   Web of Science ®Google Scholar
• Mahalaxmi R, Sastri P, Kalra A, Kanagale PD, Narkhede R. 2009. Enhancement of dissolution of glipizide from controlled porosity osmotic pump using a wicking agent and a solubilizing agent. Int J PharmTech Res. 1:705–711.
   Google Scholar
• Makhija SN, Vavia PR. 2003. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine. I. Cellulose acetate as a semipermeable membrane. J Control Release. 89:5–18.
   PubMed Web of Science ®Google Scholar
• Mao Y-T, Hua H-Y, Zhang X-G, Zhu D-X, Li F, Gui Z-H, Zhao Y-X. 2013. Ethosomes as delivery system for transdermal administration of vinpocetine. Pharmazie. 68:381–382.
   PubMed Web of Science ®Google Scholar
• Miao Y, Chen G, Ren L, Pingkai O. 2014. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect. Drug Deliv. 23:2163–2172.
   PubMed Web of Science ®Google Scholar
• Morsi NM, Ghorab DM, Badie HA. 2013. Brain targeted solid lipid nanoparticles for brain ischemia: preparation and in vitro characterization. Pharm Dev Technol. 18:736–744.
   PubMed Web of Science ®Google Scholar
• Nazzal S, Khan MA. 2006. Controlled release of a self-emulsifying formulation from a tablet dosage form: Stability assessment and optimization of some processing parameters. Int J Pharm. 315:110–121.
   PubMed Web of Science ®Google Scholar
• Nerurkar MM, Burton PS, Borchardt RT. 1996. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm Res. 13:528–534.
   PubMed Web of Science ®Google Scholar
• Nie S, Wu J, Liu H, Pan W, Liu Y. 2011. Influence of admixed citric acid and physiological variables on the vinpocetine release from sodium alginate compressed matrix tablets. Drug Dev Ind Pharm. 37:954–962.
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Hentzschel CM, Leopold CS. 2011. Drug release from liquisolid systems: speed it up, slow it down. Expert Opin Drug Deliv. 8:191–205.
   PubMed Web of Science ®Google Scholar
• Noyes AA, Whitney WR. 1897. The rate of solution of solid substances in their own solution. J Am Chem Soc. 19:930–934.
   Google Scholar
• Oh DH, Kang JH, Kim DW, Lee B-J, Kim JO, Yong CS, Choi H-G. 2011. Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. Int J Pharm. 420:412–418.
   PubMed Web of Science ®Google Scholar
• Okimoto K, Ohike A, Ibuki R, Aoki O, Ohnishi N, Rajewski RA, Stella VJ, Irie T, Uekama K. 1999. Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE) 7m-β-CD as both a solubilizer and osmotic agent. J Control Release. 60:311–319.
   PubMed Web of Science ®Google Scholar
• Park M-J, Balakrishnan P, Yang S-G. 2013. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine. Int J Pharm. 441:757–764.
   PubMed Web of Science ®Google Scholar
• Patil PR, Biradar SV, Paradkar AR. 2009. Extended release felodipine self-nanoemulsifying system. AAPS PharmSciTech. 10:515–523.
   PubMed Web of Science ®Google Scholar
• Ribeiro A, Sosnik A, Chiappetta DA, Veiga F, Concheiro A, Alvarez-Lorenzo C. 2012. Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy. J R Soc Interface. 9:2059–2069.
   PubMed Web of Science ®Google Scholar
• Ribeiro LS, Falcão AC, Patrício JA, Ferreira DC, Veiga FJ. 2007. Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine. J Pharm Sci. 96:2018–2028.
   PubMed Web of Science ®Google Scholar
• Serratoni M, Newton M, Booth S, Clarke A. 2007. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Eur J Pharm Biopharm. 65:94–98.
   PubMed Web of Science ®Google Scholar
• Shchekin AK, Rusanov AI. 2008. Generalization of the Gibbs–Kelvin–Kohler and Ostwald–Freundlich equations for a liquid film on a soluble nanoparticle. J Chem Phys. 129:154116.
   PubMed Web of Science ®Google Scholar
• Shokri J, Ahmadi P, Rashidi P, Shahsavari M, Rajabi-Siahboomi A, Nokhodchi A. 2008. Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs. Eur J Pharm Biopharm. 68:289–297.
   PubMed Web of Science ®Google Scholar
• Swenson ES, Curatolo WJ. 1992. Means to enhance penetration. Adv Drug Deliv Rev. 8:39–92.
   Web of Science ®Google Scholar
• Thombre A, Appel L, Chidlaw M, Daugherity P, Dumont F, Evans L, Sutton S. 2004. Osmotic drug delivery using swellable-core technology. J Control Release. 94:75–89.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. 1997. Guidance for Industry - Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations. https://www.fda.gov/downloads/drugs/guidances/ucm070239.pdf.
   Google Scholar
• Vereczkey L, Czira G, Tamás J, Szentirmay Z, Botár Z, Szporny L. 1979. Pharmacokinetics of vinpocetine in humans. Arzneimittelforschung. 29:957–960.
   PubMed Web of Science ®Google Scholar
• Verma RK, Krishna DM, Garg S. 2002. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release. 79:7–27.
   PubMed Web of Science ®Google Scholar
• Wang R, Xu Y. 2016. Development and evaluation of nanoparticles based on mPEG-PLA for controlled delivery of vinpocetine: in vitro and in vivo studies. Artif Cells Nanomed Biotechnol. 45:157–162
   PubMed Web of Science ®Google Scholar
• Wang Y-P, Gan Y, Zhang X-X. 2011. Novel gastroretentive sustained-release tablet of tacrolimus based on self-microemulsifying mixture: in vitro evaluation and in vivo bioavailability test. Acta Pharmacol Sin. 32:1294–1302.
   PubMed Web of Science ®Google Scholar
• Wei L, Li J, Guo L, Nie S, Pan W, Sun P, Liu H. 2007. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol. Drug Dev Ind Pharm. 33:990–998.
   PubMed Web of Science ®Google Scholar
• Yi T, Wan J, Xu H, Yang X. 2008. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose. Eur J Pharma Sci. 34:274–280.
   PubMed Web of Science ®Google Scholar
• You J, Cui F-D, Han X, Wang Y-S, Yang L, Yu Y-W, Li Q-P. 2006. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion–solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil. Colloids Surf B. 48:35–41.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yi Y, Qi J, Lu Y, Tian Z, Xie Y, Yuan H, Wu W. 2013. Controlled release of cyclosporine A self-nanoemulsifying systems from osmotic pump tablets: near zero-order release and pharmacokinetics in dogs. Int J Pharm. 452:233–240.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, Xie S. 2010. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 12:263–271.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang R, Wu J, Shen Q. 2012. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery. Int J Pharm. 427:337–344.
   PubMed Web of Science ®Google Scholar
• Zvonar A, Berginc K, Kristl A, Gašperlin M. 2010. Microencapsulation of self-microemulsifying system: improving solubility and permeability of furosemide. Int J Pharm. 388:151–158.
   PubMed Web of Science ®Google Scholar
• Zvonar A, Bolko K, Gašperlin M. 2012. Microencapsulation of self-microemulsifying systems: optimization of shell-formation phase and hardening process. Int J Pharm. 437:294–302.
   PubMed Web of Science ®Google Scholar